Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
54.37
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
34,597
Open
54.37
Bid (Size)
54.80 (2)
Ask (Size)
54.83 (8)
Prev. Close
54.37
Today's Range
54.37 - 54.37
52wk Range
45.05 - 117.96
Shares Outstanding
N/A
Dividend Yield
4.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
'No Place Is Risk-Free Until The World Is Polio-Free:' Bill Gates Urges Global Action To Close Deadly Immunity Gaps
October 19, 2025
Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.
Via
Benzinga
Benzinga Bulls And Bears: Stellantis, Papa John's, Oklo — And Trade Tensions Shake Chip Stocks
October 18, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via
Benzinga
Topics
World Trade
Performance
YTD
-37.9%
-37.9%
1 Month
-11.4%
-11.4%
3 Month
-16.3%
-16.3%
6 Month
-6.8%
-6.8%
1 Year
-53.7%
-53.7%
More News
Read More
Trump's Weight-Loss Drug Push May Put These ETFs On A Diet
October 17, 2025
Via
Benzinga
Topics
ETFs
Government
Omeros Corp Stock Soars A Whopping 136% Pre-Market After Novo Nordisk Agrees To Buy Its Drug Candidate For Blood Disorder
October 15, 2025
Via
Stocktwits
Trump-Induced Volatility Aside, Novo Trades Cheap While Patents Protect Its Profits Until 2032
October 17, 2025
Via
Benzinga
Topics
Government
Intellectual Property
Novo Nordisk Stock Is Falling Friday: What's Driving The Action?
October 17, 2025
Via
Benzinga
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.
October 17, 2025
Via
Investor's Business Daily
Topics
Government
Novo Nordisk Hires US Pharma Veteran After Trump Touts ‘Much Lower’ Prices Of Ozempic
October 17, 2025
Via
Stocktwits
Topics
Government
Eli Lilly Shares Are Trading Lower Friday: What's Going On?
October 17, 2025
Via
Benzinga
Topics
Government
Novo Vs. Lilly Vs. Pfizer: Who Wins If Trump Slashes The Price Of Weight Loss Drugs?
October 17, 2025
Via
Benzinga
Topics
Government
Market Jitters: Dow Dips Amid Bank Fears While Eli Lilly and Novo Nordisk Tumble on Trump's Drug Pricing Comments
October 17, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Regional Banks’ Credit Concerns Drag Dow Futures: NVO, WAL, ZION, IBKR Among Stocks To Watch
October 17, 2025
Via
Stocktwits
Topics
ETFs
Earnings
Fraud
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
October 17, 2025
Via
The Motley Fool
Eli Lilly, Novo Nordisk Stocks Fall After-Hours As Trump Pledges Swift Price Cuts For ‘Fat-Loss Drugs’
October 16, 2025
Via
Stocktwits
Topics
Economy
Government
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'
October 16, 2025
Via
Benzinga
Topics
Government
What's Driving the Market Sentiment Around Novo Nordisk AS?
October 16, 2025
Via
Benzinga
Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem
October 16, 2025
Via
Benzinga
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
October 16, 2025
Via
The Motley Fool
Omeros Stock Logs Best Session Ever After HC Wainwright Doubles Target On Novo Nordisk Deal; Retail Sees Big Upside
October 15, 2025
Via
Stocktwits
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
October 15, 2025
Via
MarketBeat
Topics
World Trade
Omeros Stock Skyrockets After Novo Nordisk Strikes $2.1B Rare Disease Drug Deal
October 15, 2025
Via
Benzinga
Meet the 1.4% Yield Dividend Stock That Could Soar in 2026
October 15, 2025
Via
The Motley Fool
Why Is Scholar Rock Stock Trading Lower On Monday?
October 13, 2025
Via
Benzinga
Why Are Regeneron And Scholar Rock Shares Falling On Monday?
October 13, 2025
Via
Stocktwits
Down 44%, Should You Buy the Dip on Viking Therapeutics?
October 13, 2025
Via
The Motley Fool
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 54.37
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 10/17/25 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today